Arthritis Research & Therapy

official impact factor 4.36

Email this article to a friend

How can we reduce the risk of serious infection for patients with systemic lupus erythematosus?

Diane L Kamen

Arthritis Research & Therapy 2009, 11:129 doi:10.1186/ar2818


See related research by Ruiz-Irastorza et al., http://arthritis-research.com/content/11/4/R109

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.